Co-Diagnostics, Inc. - Common Stock (CODX)
2.5900
-0.0600 (-2.26%)
NASDAQ · Last Trade: Mar 20th, 4:32 PM EDT
Detailed Quote
| Previous Close | 2.650 |
|---|---|
| Open | 3.860 |
| Bid | 2.490 |
| Ask | 2.540 |
| Day's Range | 2.470 - 3.950 |
| 52 Week Range | 2.176 - 46.50 |
| Volume | 56,477,264 |
| Market Cap | 157.71M |
| PE Ratio (TTM) | -2.616 |
| EPS (TTM) | -1.0 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 727,961 |
Chart
About Co-Diagnostics, Inc. - Common Stock (CODX)
Co-Diagnostics Inc is a biotechnology company that focuses on the development and manufacturing of molecular diagnostic tests used to detect diseases. The company specializes in the design of innovative testing solutions that leverage its proprietary technologies for amplification and detection of nucleic acids. Co-Diagnostics aims to provide accurate and timely diagnostic tools that facilitate the identification of various pathogens, aiding in disease prevention and management. Through its commitment to enhancing diagnostic capabilities, the company supports healthcare providers and public health initiatives. Read More
News & Press Releases
MissionIRNewsBreaks – Co-Diagnostics, Inc. (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia
Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal and Sri Lanka, significantly increasing its addressable market to an estimated $13.0 billion. The expansion supports planned commercialization of the CoSara PCR Pro(R) point-of-care platform and SARAGENE(R) product line, subject to regulatory approvals, as the company builds regional distribution channels and positions for broader deployment of its molecular diagnostics solutions.
Via Investor Brand Network · March 20, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · March 20, 2026
Keep an eye on the top gainers and losers in Tuesday's session.chartmill.com
Via Chartmill · January 13, 2026
After the reverse split becomes effective, Co-Diagnostics will have around 2.1 million outstanding shares.
Via Stocktwits · December 30, 2025
Co-Diagnostics (CODX) reported mixed Q3 2025 results, beating EPS estimates but missing on revenue. The stock fell over 4% after-hours.
Via Chartmill · November 13, 2025
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript
Via The Motley Fool · November 13, 2025
SALT LAKE CITY, UT – November 3, 2025 – In a significant leap forward for medical technology, Co-Diagnostics, Inc. (NASDAQ: CODX) today announced the integration of advanced artificial intelligence into its proprietary Co-Dx™ Primer Ai™ platform. This strategic move, highlighted by a GuruFocus report, positions AI at the forefront of molecular diagnostics, promising to fundamentally [...]
Via TokenRing AI · November 3, 2025
Via Benzinga · October 29, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · October 28, 2025
Unusual volume stocks are being observed in Tuesday's session.
Via Chartmill · October 28, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · October 28, 2025
Via Benzinga · October 28, 2025
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.
Via Benzinga · October 28, 2025
Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 28, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · October 28, 2025
Via Benzinga · October 28, 2025
Via Benzinga · October 28, 2025
Verizon Communications Inc. (NYSE: VZ) has announced its intent to acquire Starry Internet, a fixed wireless access (FWA) provider utilizing millimeter-wave (mmWave) technology to deliver high-speed broadband in dense urban markets. The acquisition is expected to be completed in the first quarter of 2026, pending regulatory approvals and customary closing conditions.
Via AB Newswire · October 27, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · October 27, 2025
Via Benzinga · October 27, 2025
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · October 27, 2025